Company Monitoring Page for JNJ

latest headlines for company on cafepharma

Anemic Growth? Not From These Drugs.
Motley Fool
Sat, 04/28/12 - 12:19 pm
Tags:
Amgen, Affymax, Takeda, Epogen, Aranesp, Pfizer, Abbott Laboratories, JNJ, Novartis, Zometa, Xgeva, Prolia
New J&J CEO plans realistic, optimistic future
Yahoo/AP
Thu, 04/26/12 - 09:27 am
Tags:
JNJ, Pharma CEOs, Alex Gorsky
Two Hepatitis C Treatments Win U.K. Health-Cost Agency Backing
Bloomberg
Wed, 04/25/12 - 10:17 am
Tags:
hepatitis C, Victrelis, Merck, UK, JNJ, Incivo
J&J Sticking Together
Investopedia.com
Tue, 04/24/12 - 10:07 am
Tags:
JNJ, Novartis, Pfizer, Abbott Laboratories, Zimmer, Stryker
Cure Worms, Make Money
Motley Fool
Sat, 04/21/12 - 12:24 pm
Tags:
GSK, tropical diseases, Novartis, Pfizer, Abbott Laboratories, JNJ
5 Biotech Stocks That Could Soar On New Hepatitis C Drugs
Seeking Alpha
Sat, 04/21/12 - 12:17 pm
Tags:
Vertex, Incivek, ABT-072, ABT-450, Abbott Laboratories, Achillion, ACH-1625, ACH-2684, ACH-2928, ACH-3102, TMC435, JNJ, GSK, hepatitis C
Partner Up or Get Passed Up
Motley Fool
Sat, 04/21/12 - 11:51 am
Tags:
GS-7977, Vertex Pharmaceuticals, hepatitis C, Roche, Bristol-Myers Squibb, Merck, Gilead Sciences, JNJ
Human Genome Sciences: Analyzing The Road Ahead Now That It Is In Play
Seeking Alpha
Fri, 04/20/12 - 10:51 am
Tags:
Human Genome Sciences, Abbott Laboratories, Amgen, Amylin, Bristol-Myers Squibb, GSK, JNJ, Illumina, Merck, M&A
Johnson & Johnson: Synthes Approval Will Push Stock Higher
Seeking Alpha
Fri, 04/20/12 - 10:45 am
Tags:
JNJ, Synthes, M&A
J&J Open to Expanding Hepatitis C Collaboration With Vertex
Bloomberg
Fri, 04/20/12 - 10:35 am
Tags:
hepatitis C, JNJ, Vertex
Johnson & Johnson Raises Forecast; Will Other Drug Companies Follow Suit?
Motley Fool
Thu, 04/19/12 - 11:48 am
Tags:
JNJ, guidance
Johnson & Johnson Will Tumble On Risperdal Lawsuit, Bad PR
Seeking Alpha
Thu, 04/19/12 - 10:41 am
Tags:
JNJ, Risperdal
EU OKs J&J's $21.3B Synthes Takeover: Hot Trends
TheStreet.com
Thu, 04/19/12 - 10:35 am
Tags:
Europe, JNJ, Synthes, M&A
Eli Lilly Will Sink If Solanezumab Fails
Seeking Alpha
Wed, 04/18/12 - 11:42 am
Tags:
solanezumab, Eli Lilly, GSK, JNJ, Pfizer, Sanofi, Alzheimer's disease
Popular J.&J. Drugs May Not Return Until 2013
NY Times, NY
Wed, 04/18/12 - 09:13 am
Tags:
JNJ
New J&J CEO's ties to fraud case show J&J sees no need for a cure
Forbes
Tue, 04/17/12 - 10:59 am
Tags:
JNJ, fraud, Alex Gorsky
2012 Is Looking Like A Turning Point For J&J
Seeking Alpha
Tue, 04/17/12 - 10:20 am
Tags:
JNJ, Abbott Laboratories, Covidien, Stryker
Johnson & Johnson Reports Mixed First Quarter Earnings
Yahoo/Business Insider
Tue, 04/17/12 - 08:00 am
Tags:
JNJ, earnings
J&J Must Pay $40 Million to Boston Scientific, Judge Says
Bloomberg
Mon, 04/16/12 - 04:01 pm
Tags:
JNJ, Boston Scientific, settlements, patents, coronary stent system
Johnson & Johnson Won't Blow Out Earnings But Still Worth $72.50
Forbes
Mon, 04/16/12 - 11:28 am
Tags:
JNJ, earnings

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.